APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bovine Medicine and Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bovine Medicine and Vaccines Market Outlook and Growth Opportunities 2026

2 January 2026208 pages

Choose your research edition.

Industry ResearchBovine Medicine and Vaccines Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Bovine Medicine and Vaccines Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Bovine Medicine and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bovine Medicine and Vaccines Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Bovine Medicine and Vaccines Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Bovine Medicine and Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bovine Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bovine Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bovine Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bovine Medicine and Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bovine Medicine and Vaccines market include Agrovet, Bayer HealthCare, BIGVET Biotech, Biogenesis Bagó, Boehringer Ingelheim, Brilliant Bio Pharma, BVI, CAHIC and Cavet Bio, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Bovine Medicine and Vaccines market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bovine Medicine and Vaccines and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bovine Medicine and Vaccines revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Bovine Medicine and Vaccines market.

Bovine Medicine and Vaccines Segment by Company

Agrovet

Bayer HealthCare

BIGVET Biotech

Biogenesis Bagó

Boehringer Ingelheim

Brilliant Bio Pharma

BVI

CAHIC

Cavet Bio

CEVA

Indian Immunologicals

LIMOR

ME VAC

MSD Animal Health

Sanofi (Merial)

Shen Lian

Tecon Group

VECOL

VETAL

Jinyu Group

Bovine Medicine and Vaccines Segment by Type

Medicine

Vaccines

Bovine Medicine and Vaccines Segment by Application

Farm

Government

Bovine Medicine and Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Bovine Medicine and Vaccines status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Bovine Medicine and Vaccines key companies, revenue, market share, and recent developments.

3. To split the Bovine Medicine and Vaccines breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Bovine Medicine and Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bovine Medicine and Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Bovine Medicine and Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bovine Medicine and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bovine Medicine and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bovine Medicine and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bovine Medicine and Vaccines industry.

Chapter 3: Detailed analysis of Bovine Medicine and Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Bovine Medicine and Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Bovine Medicine and Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bovine Medicine and Vaccines Industry Trends Table 2. Bovine Medicine and Vaccines Industry Drivers Table 3. Bovine Medicine and Vaccines Industry Opportunities and Challenges Table 4. Bovine Medicine and Vaccines Industry Restraints Table 5. Global Bovine Medicine and Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bovine Medicine and Vaccines Revenue Share by Company (2021-2026) Table 7. Global Bovine Medicine and Vaccines Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Bovine Medicine and Vaccines Key Company Manufacturing Base & Headquarters Table 9. Global Bovine Medicine and Vaccines Company, Product Type & Application Table 10. Global Bovine Medicine and Vaccines Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Bovine Medicine and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Medicine Table 15. Significant Companies of Vaccines Table 16. Global Bovine Medicine and Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Bovine Medicine and Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Bovine Medicine and Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Bovine Medicine and Vaccines Sales Value Share by Type (2021-2026) Table 20. Global Bovine Medicine and Vaccines Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Farm Table 22. Significant Companies of Government Table 23. Global Bovine Medicine and Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Bovine Medicine and Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Bovine Medicine and Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Bovine Medicine and Vaccines Sales Value Share by Application (2021-2026) Table 27. Global Bovine Medicine and Vaccines Sales Value Share by Application (2027-2032) Table 28. Global Bovine Medicine and Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Bovine Medicine and Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Bovine Medicine and Vaccines Sales Value Share by Region (2021-2026) Table 31. Global Bovine Medicine and Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Bovine Medicine and Vaccines Sales Value Share by Region (2027-2032) Table 33. Global Bovine Medicine and Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Bovine Medicine and Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Bovine Medicine and Vaccines Sales Value Market Share by Country (2021-2026) Table 36. Global Bovine Medicine and Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Bovine Medicine and Vaccines Sales Value Market Share by Country (2027-2032) Table 38. Agrovet Company Information Table 39. Agrovet Business Overview Table 40. Agrovet Bovine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Agrovet Bovine Medicine and Vaccines Product Portfolio Table 42. Agrovet Recent Development Table 43. Bayer HealthCare Company Information Table 44. Bayer HealthCare Business Overview Table 45. Bayer HealthCare Bovine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Bayer HealthCare Bovine Medicine and Vaccines Product Portfolio Table 47. Bayer HealthCare Recent Development Table 48. BIGVET Biotech Company Information Table 49. BIGVET Biotech Business Overview Table 50. BIGVET Biotech Bovine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. BIGVET Biotech Bovine Medicine and Vaccines Product Portfolio Table 52. BIGVET Biotech Recent Development Table 53. Biogenesis Bagó Company Information Table 54. Biogenesis Bagó Business Overview Table 55. Biogenesis Bagó Bovine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Biogenesis Bagó Bovine Medicine and Vaccines Product Portfolio Table 57. Biogenesis Bagó Recent Development Table 58. Boehringer Ingelheim Company Information Table 59. Boehringer Ingelheim Business Overview Table 60. Boehringer Ingelheim Bovine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Boehringer Ingelheim Bovine Medicine and Vaccines Product Portfolio Table 62. Boehringer Ingelheim Recent Development Table 63. Brilliant Bio Pharma Company Information Table 64. Brilliant Bio Pharma Business Overview Table 65. Brilliant Bio Pharma Bovine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Brilliant Bio Pharma Bovine Medicine and Vaccines Product Portfolio Table 67. Brilliant Bio Pharma Recent Development Table 68. BVI Company Information Table 69. BVI Business Overview Table 70. BVI Bovine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. BVI Bovine Medicine and Vaccines Product Portfolio Table 72. BVI Recent Development Table 73. CAHIC Company Information Table 74. CAHIC Business Overview Table 75. CAHIC Bovine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. CAHIC Bovine Medicine and Vaccines Product Portfolio Table 77. CAHIC Recent Development Table 78. Cavet Bio Company Information Table 79. Cavet Bio Business Overview Table 80. Cavet Bio Bovine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Cavet Bio Bovine Medicine and Vaccines Product Portfolio Table 82. Cavet Bio Recent Development Table 83. CEVA Company Information Table 84. CEVA Business Overview Table 85. CEVA Bovine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. CEVA Bovine Medicine and Vaccines Product Portfolio Table 87. CEVA Recent Development Table 88. Indian Immunologicals Company Information Table 89. Indian Immunologicals Business Overview Table 90. Indian Immunologicals Bovine Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Indian Immunologicals Bovine Medicine and Vaccines Product Portfolio Table 92. Indian Immunologicals Recent Development Table 93. LIMOR Company Information Table 94. LIMOR Business Overview Table 95. LIMOR Bovine Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. LIMOR Bovine Medicine and Vaccines Product Portfolio Table 97. LIMOR Recent Development Table 98. ME VAC Company Information Table 99. ME VAC Business Overview Table 100. ME VAC Bovine Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. ME VAC Bovine Medicine and Vaccines Product Portfolio Table 102. ME VAC Recent Development Table 103. MSD Animal Health Company Information Table 104. MSD Animal Health Business Overview Table 105. MSD Animal Health Bovine Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. MSD Animal Health Bovine Medicine and Vaccines Product Portfolio Table 107. MSD Animal Health Recent Development Table 108. Sanofi (Merial) Company Information Table 109. Sanofi (Merial) Business Overview Table 110. Sanofi (Merial) Bovine Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Sanofi (Merial) Bovine Medicine and Vaccines Product Portfolio Table 112. Sanofi (Merial) Recent Development Table 113. Shen Lian Company Information Table 114. Shen Lian Business Overview Table 115. Shen Lian Bovine Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Shen Lian Bovine Medicine and Vaccines Product Portfolio Table 117. Shen Lian Recent Development Table 118. Tecon Group Company Information Table 119. Tecon Group Business Overview Table 120. Tecon Group Bovine Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Tecon Group Bovine Medicine and Vaccines Product Portfolio Table 122. Tecon Group Recent Development Table 123. VECOL Company Information Table 124. VECOL Business Overview Table 125. VECOL Bovine Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. VECOL Bovine Medicine and Vaccines Product Portfolio Table 127. VECOL Recent Development Table 128. VETAL Company Information Table 129. VETAL Business Overview Table 130. VETAL Bovine Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. VETAL Bovine Medicine and Vaccines Product Portfolio Table 132. VETAL Recent Development Table 133. Jinyu Group Company Information Table 134. Jinyu Group Business Overview Table 135. Jinyu Group Bovine Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Jinyu Group Bovine Medicine and Vaccines Product Portfolio Table 137. Jinyu Group Recent Development Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Bovine Medicine and Vaccines Product Image Figure 2. Global Bovine Medicine and Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bovine Medicine and Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Bovine Medicine and Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Medicine Image Figure 8. Vaccines Image Figure 9. Global Bovine Medicine and Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Bovine Medicine and Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Bovine Medicine and Vaccines Sales Value Share by Type (2021-2032) Figure 12. Farm Image Figure 13. Government Image Figure 14. Global Bovine Medicine and Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Bovine Medicine and Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Bovine Medicine and Vaccines Sales Value Share by Application (2021-2032) Figure 17. Global Bovine Medicine and Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Bovine Medicine and Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Bovine Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 20. North America Bovine Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Bovine Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Bovine Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Bovine Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Bovine Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Bovine Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 26. South America Bovine Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Bovine Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Bovine Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Medicine
  • Vaccines
Applications
  • Farm
  • Government
Companies covered
  • Agrovet
  • Bayer HealthCare
  • BIGVET Biotech
  • Biogenesis Bagó
  • Boehringer Ingelheim
  • Brilliant Bio Pharma
  • BVI
  • CAHIC
  • Cavet Bio
  • CEVA
  • Indian Immunologicals
  • LIMOR
  • ME VAC
  • MSD Animal Health
  • Sanofi (Merial)
  • Shen Lian
  • Tecon Group
  • VECOL
  • VETAL
  • Jinyu Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bovine Medicine and Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bovine Medicine and Vaccines Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Bovine Medicine and Vaccines Market Dynamics
  1. 2.1 Bovine Medicine and Vaccines Industry Trends
  2. 2.2 Bovine Medicine and Vaccines Industry Drivers
  3. 2.3 Bovine Medicine and Vaccines Industry Opportunities and Challenges
  4. 2.4 Bovine Medicine and Vaccines Industry Restraints
3 Bovine Medicine and Vaccines Market by Company
  1. 3.1 Global Bovine Medicine and Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Bovine Medicine and Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Bovine Medicine and Vaccines Company Ranking (2024-2026)
  4. 3.4 Global Bovine Medicine and Vaccines Company Manufacturing Base and Headquarters
  5. 3.5 Global Bovine Medicine and Vaccines Company Product Type and Application
  6. 3.6 Global Bovine Medicine and Vaccines Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Bovine Medicine and Vaccines Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Bovine Medicine and Vaccines Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Bovine Medicine and Vaccines Market by Type
  1. 4.1 Bovine Medicine and Vaccines Type Introduction
  2. 4.1.1 Medicine
  3. 4.1.2 Vaccines
  4. 4.2 Global Bovine Medicine and Vaccines Sales Value by Type
  5. 4.2.1 Global Bovine Medicine and Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bovine Medicine and Vaccines Sales Value by Type (2021-2032)
  7. 4.2.3 Global Bovine Medicine and Vaccines Sales Value Share by Type (2021-2032)
5 Bovine Medicine and Vaccines Market by Application
  1. 5.1 Bovine Medicine and Vaccines Application Introduction
  2. 5.1.1 Farm
  3. 5.1.2 Government
  4. 5.2 Global Bovine Medicine and Vaccines Sales Value by Application
  5. 5.2.1 Global Bovine Medicine and Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Bovine Medicine and Vaccines Sales Value by Application (2021-2032)
  7. 5.2.3 Global Bovine Medicine and Vaccines Sales Value Share by Application (2021-2032)
6 Bovine Medicine and Vaccines Regional Value Analysis
  1. 6.1 Global Bovine Medicine and Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bovine Medicine and Vaccines Sales Value by Region (2021-2032)
  3. 6.2.1 Global Bovine Medicine and Vaccines Sales Value by Region: 2021-2026
  4. 6.2.2 Global Bovine Medicine and Vaccines Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bovine Medicine and Vaccines Sales Value (2021-2032)
  7. 6.3.2 North America Bovine Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Bovine Medicine and Vaccines Sales Value (2021-2032)
  10. 6.4.2 Europe Bovine Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Bovine Medicine and Vaccines Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Bovine Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Bovine Medicine and Vaccines Sales Value (2021-2032)
  16. 6.6.2 South America Bovine Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Bovine Medicine and Vaccines Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Bovine Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
7 Bovine Medicine and Vaccines Country-level Value Analysis
  1. 7.1 Global Bovine Medicine and Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bovine Medicine and Vaccines Sales Value by Country (2021-2032)
  3. 7.2.1 Global Bovine Medicine and Vaccines Sales Value by Country (2021-2026)
  4. 7.2.2 Global Bovine Medicine and Vaccines Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Bovine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Bovine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Bovine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Agrovet
  2. 8.1.1 Agrovet Company Information
  3. 8.1.2 Agrovet Business Overview
  4. 8.1.3 Agrovet Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Agrovet Bovine Medicine and Vaccines Product Portfolio
  6. 8.1.5 Agrovet Recent Developments
  7. 8.2 Bayer HealthCare
  8. 8.2.1 Bayer HealthCare Company Information
  9. 8.2.2 Bayer HealthCare Business Overview
  10. 8.2.3 Bayer HealthCare Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bayer HealthCare Bovine Medicine and Vaccines Product Portfolio
  12. 8.2.5 Bayer HealthCare Recent Developments
  13. 8.3 BIGVET Biotech
  14. 8.3.1 BIGVET Biotech Company Information
  15. 8.3.2 BIGVET Biotech Business Overview
  16. 8.3.3 BIGVET Biotech Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BIGVET Biotech Bovine Medicine and Vaccines Product Portfolio
  18. 8.3.5 BIGVET Biotech Recent Developments
  19. 8.4 Biogenesis Bagó
  20. 8.4.1 Biogenesis Bagó Company Information
  21. 8.4.2 Biogenesis Bagó Business Overview
  22. 8.4.3 Biogenesis Bagó Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Biogenesis Bagó Bovine Medicine and Vaccines Product Portfolio
  24. 8.4.5 Biogenesis Bagó Recent Developments
  25. 8.5 Boehringer Ingelheim
  26. 8.5.1 Boehringer Ingelheim Company Information
  27. 8.5.2 Boehringer Ingelheim Business Overview
  28. 8.5.3 Boehringer Ingelheim Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Boehringer Ingelheim Bovine Medicine and Vaccines Product Portfolio
  30. 8.5.5 Boehringer Ingelheim Recent Developments
  31. 8.6 Brilliant Bio Pharma
  32. 8.6.1 Brilliant Bio Pharma Company Information
  33. 8.6.2 Brilliant Bio Pharma Business Overview
  34. 8.6.3 Brilliant Bio Pharma Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Brilliant Bio Pharma Bovine Medicine and Vaccines Product Portfolio
  36. 8.6.5 Brilliant Bio Pharma Recent Developments
  37. 8.7 BVI
  38. 8.7.1 BVI Company Information
  39. 8.7.2 BVI Business Overview
  40. 8.7.3 BVI Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BVI Bovine Medicine and Vaccines Product Portfolio
  42. 8.7.5 BVI Recent Developments
  43. 8.8 CAHIC
  44. 8.8.1 CAHIC Company Information
  45. 8.8.2 CAHIC Business Overview
  46. 8.8.3 CAHIC Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CAHIC Bovine Medicine and Vaccines Product Portfolio
  48. 8.8.5 CAHIC Recent Developments
  49. 8.9 Cavet Bio
  50. 8.9.1 Cavet Bio Company Information
  51. 8.9.2 Cavet Bio Business Overview
  52. 8.9.3 Cavet Bio Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cavet Bio Bovine Medicine and Vaccines Product Portfolio
  54. 8.9.5 Cavet Bio Recent Developments
  55. 8.10 CEVA
  56. 8.10.1 CEVA Company Information
  57. 8.10.2 CEVA Business Overview
  58. 8.10.3 CEVA Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CEVA Bovine Medicine and Vaccines Product Portfolio
  60. 8.10.5 CEVA Recent Developments
  61. 8.11 Indian Immunologicals
  62. 8.11.1 Indian Immunologicals Company Information
  63. 8.11.2 Indian Immunologicals Business Overview
  64. 8.11.3 Indian Immunologicals Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Indian Immunologicals Bovine Medicine and Vaccines Product Portfolio
  66. 8.11.5 Indian Immunologicals Recent Developments
  67. 8.12 LIMOR
  68. 8.12.1 LIMOR Company Information
  69. 8.12.2 LIMOR Business Overview
  70. 8.12.3 LIMOR Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  71. 8.12.4 LIMOR Bovine Medicine and Vaccines Product Portfolio
  72. 8.12.5 LIMOR Recent Developments
  73. 8.13 ME VAC
  74. 8.13.1 ME VAC Company Information
  75. 8.13.2 ME VAC Business Overview
  76. 8.13.3 ME VAC Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ME VAC Bovine Medicine and Vaccines Product Portfolio
  78. 8.13.5 ME VAC Recent Developments
  79. 8.14 MSD Animal Health
  80. 8.14.1 MSD Animal Health Company Information
  81. 8.14.2 MSD Animal Health Business Overview
  82. 8.14.3 MSD Animal Health Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  83. 8.14.4 MSD Animal Health Bovine Medicine and Vaccines Product Portfolio
  84. 8.14.5 MSD Animal Health Recent Developments
  85. 8.15 Sanofi (Merial)
  86. 8.15.1 Sanofi (Merial) Company Information
  87. 8.15.2 Sanofi (Merial) Business Overview
  88. 8.15.3 Sanofi (Merial) Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Sanofi (Merial) Bovine Medicine and Vaccines Product Portfolio
  90. 8.15.5 Sanofi (Merial) Recent Developments
  91. 8.16 Shen Lian
  92. 8.16.1 Shen Lian Company Information
  93. 8.16.2 Shen Lian Business Overview
  94. 8.16.3 Shen Lian Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Shen Lian Bovine Medicine and Vaccines Product Portfolio
  96. 8.16.5 Shen Lian Recent Developments
  97. 8.17 Tecon Group
  98. 8.17.1 Tecon Group Company Information
  99. 8.17.2 Tecon Group Business Overview
  100. 8.17.3 Tecon Group Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Tecon Group Bovine Medicine and Vaccines Product Portfolio
  102. 8.17.5 Tecon Group Recent Developments
  103. 8.18 VECOL
  104. 8.18.1 VECOL Company Information
  105. 8.18.2 VECOL Business Overview
  106. 8.18.3 VECOL Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  107. 8.18.4 VECOL Bovine Medicine and Vaccines Product Portfolio
  108. 8.18.5 VECOL Recent Developments
  109. 8.19 VETAL
  110. 8.19.1 VETAL Company Information
  111. 8.19.2 VETAL Business Overview
  112. 8.19.3 VETAL Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  113. 8.19.4 VETAL Bovine Medicine and Vaccines Product Portfolio
  114. 8.19.5 VETAL Recent Developments
  115. 8.20 Jinyu Group
  116. 8.20.1 Jinyu Group Company Information
  117. 8.20.2 Jinyu Group Business Overview
  118. 8.20.3 Jinyu Group Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Jinyu Group Bovine Medicine and Vaccines Product Portfolio
  120. 8.20.5 Jinyu Group Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst